Is Hydroxyapatite Toothpaste Safe? What EU Documents Reveal

Introduction

Hydroxyapatite toothpaste has become increasingly popular in recent years.

Supporters often describe it as a modern alternative to traditional fluoride toothpaste, especially for people interested in remineralization and gentler oral care.

But few people realize that behind the scenes, European regulators have spent years reviewing one specific version of the ingredient.

Not because hydroxyapatite toothpaste was banned.

Not because regulators concluded it was unsafe.

But because they wanted more evidence.

After reviewing publicly released European Commission documents and Scientific Committee material, a more interesting picture appears:

This wasn’t a story of approval or rejection.

It was a story of scientific uncertainty, additional evidence, and changing conclusions over time.

First: What Is Hydroxyapatite?

Hydroxyapatite is a calcium phosphate material naturally present in teeth and bones.

In oral care products it is commonly marketed as helping support enamel appearance and surface repair.

The documents provided to the European Commission specifically discuss Hydroxyapatite (nano) used in oral cosmetic products.

That distinction matters.

Because regulators treated the nano form differently from ordinary ingredients.

Why Did the EU Start Looking More Closely?

Under EU cosmetic rules, intentionally manufactured nanomaterials can trigger additional review requirements and notification obligations before products reach the market.

According to Commission documents, authorities received notifications for cosmetic products containing Hydroxyapatite (nano), which led to formal scientific review requests to the Scientific Committee on Consumer Safety (SCCS).

Hydroxyapatite itself was described as being used as:

abrasive agent
bulking agent
oral care ingredient
skin-conditioning ingredient

The question regulators asked was not:

“Does hydroxyapatite work?”

The question was:

“Under what conditions can this nano form be considered safe?”

The Part Most Headlines Skip: Regulators Initially Could Not Reach a Conclusion

This is probably the most misunderstood part.

The SCCS did not initially conclude that Hydroxyapatite (nano) was unsafe.

Instead, according to Commission documents:

in 2015
and again in 2021

The committee stated that it could not conclude on the safety of the submitted form and specifications.

The documents also note that the available information was insufficient to exclude concerns about the nano material’s possible genotoxic potential.

That distinction matters.

Not enough evidence is not the same thing as evidence of harm.

What Changed?

After those earlier reviews, additional information was submitted.

The Commission documents state that industry later provided further data intended to support safety assessment, specifically addressing earlier concerns.

Following that review process, SCCS reached a more defined conclusion.

According to the 2023 assessment referenced in the documents:

Hydroxyapatite (nano) was considered safe:

in toothpaste up to 10%
in mouthwash up to 0.465%

—but only under defined conditions regarding particle shape and specifications.

Then Something Unexpected Happened

The story didn’t stop there.

In response to the Commission’s request, the industry later submitted additional material to support evaluation at higher concentrations than those previously assessed.

That triggered another scientific request.

This is actually a good example of how modern regulation often works:

data arrives
conclusions evolve
assessments are revisited

So… Is Hydroxyapatite Toothpaste Safe?

Based on the documents reviewed:

The EU process does not support a simple yes-or-no answer.

Instead, the process suggests something more nuanced:

Specific forms, specifications, and concentrations may be considered acceptable under defined conditions after scientific review.

That is different from saying:

all forms are automatically safe
all forms are unsafe
all products are equivalent

Consumers often talk about ingredients as if they exist in isolation.

Regulators rarely do.

What Consumers Can Learn From This

Three things stood out while reading the documents:

1. Ingredients are rarely judged in isolation

Particle size, concentration, and exposure conditions matter.

2. Scientific uncertainty is normal

Requesting more evidence does not automatically imply danger.

3. Regulatory conclusions evolve

Today’s accepted use conditions may not be identical tomorrow.

Final Thoughts

One of the most surprising parts of reading the documents wasn’t that regulators asked questions.

It was that they kept asking questions.

Not because they had reached a dramatic conclusion.

But because they wanted stronger evidence.

That process may not generate viral headlines.

But it probably generates better science.

Sources & methodology

This article was prepared using European Commission correspondence and attached SCCS request documents released through an EU access-to-documents request.

Documents reviewed include:

Rickard Österholm

Is Hydroxyapatite Toothpaste Safe? What EU Documents Actually Reveal